Home » Topics » BioWorld Science

BioWorld Science
RSS

T-cell evasion is one pressure shaping SARS-CoV-2 evolution

Feb. 14, 2022

JN Nova advances COVID-19 therapeutic JN-2019 into clinic

Feb. 14, 2022

3-beta-HSD linked to depression in males due to testosterone degradation

Feb. 14, 2022

R2M3-26, a novel Wnt mimetic with promising efficacy in mouse model of colitis

Feb. 14, 2022

STC-2 administration confers post-stroke functional recovery in a preclinical model

Feb. 14, 2022

SAF-248 shows potent activity against DLBCL in vitro and in vivo

Feb. 14, 2022

Targeting sphingolipid synthesis has multiple beneficial effects in Duchenne model

Feb. 14, 2022

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical identify new SOS1 inhibitors

Feb. 14, 2022

Roche patents vasopressin V1A receptor antagonists

Feb. 14, 2022

Janssen Pharmaceutica presents new factor XIa inhibitors

Feb. 14, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...